The Mechanism of Enterohepatic Circulation in the Formation of Gallstone Disease
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Bile acids entering into enterohepatic circulating are primary acids synthesized from cholesterol in hepatocyte. They are secreted actively across canalicular membrane and carried in bile to gallbladder, where they are concentrated during digestion. About 95% BAs are actively taken up from the lumen of terminal ileum efficiently, leaving only approximately 5% (or approximately 0.5 g/d) in colon, and a fraction of bile acids are passively reabsorbed after a series of modifications in the human large intestine including deconjugation and oxidation of hydroxy groups. Bile salts hydrolysis and hydroxy group dehydrogenation reactions are performed by a broad spectrum of intestinal anaerobic bacteria. Next, hepatocyte reabsorbs bile acids from sinusoidal blood, which are carried to liver through portal vein via a series of transporters. Bile acids (BAs) transporters are critical for maintenance of the enterohepatic BAs circulation, where BAs exert their multiple physiological functions including stimulation of bile flow, intestinal absorption of lipophilic nutrients, solubilization, and excretion of cholesterol. Tight regulation of BA transporters via nuclear receptors (NRs) is necessary to maintain proper BA homeostasis. In conclusion, disturbances of enterohepatic circulation may account for pathogenesis of gallstones diseases, including BAs transporters and their regulatory NRs and the metabolism of intestinal bacterias, etc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340 · cited 1×
“…such as bile salts, bilirubin glucuronides, thyroid hormones and steroid hormone metabolites, and clinically frequently used drugs like statins, HIV protease inhibitors, and the anti-cancer agents irinotecan or methotrexate (Hagenbuch 2004; Giacomini et al. 2010; Niemi 2011; Nies et al. 2008).”
BackgroundBile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · cited 3×
“Ileal bile salt transport is highly efficient (about 95 %), but approximately 400–800 mg of bile salts escapes the enterohepatic circulation daily and becomes substrate for significant microbial biotransforming reactions in the large bowel (Ridlon et al. 2006).”
BackgroundIdentification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
An ecological and evolutionary perspective on human–microbe mutualism and disease
Dethlefsen, L., McFall-Ngai, M., & Relman, D. A. (2007) · Nature · doi:10.1038/nature06245 · Cited by 1,660 · cited 2×
“A key function of PPARa is the regulation of genes involved in various steps of fatty acid metabolism (Desvergne and Wahli 1999) and PPARa ligands include fatty acids and fibrate drugs.”
BackgroundThe burden of selected digestive diseases in the United States
Sandler, R. S., Everhart, J. E., Donowitz, M., Adams, E., Cronin, K., Goodman, C., Gemmen, E., Shah, S., Avdic, A., & Rubin, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32978 · Cited by 1,512
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
Jones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999 · cited 1×
“Moreover, between 20 and 40 % of gallstone patients become symptomatic or develop complications (Gibney 1990), and more than 700,000 people in the US and 170,000 in Germany underwent cholecystectomies annually (Sandler et al. 2002).”
BackgroundIdentification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916 · cited 4×
“These genes include MRP2 (Kast et al. 2002) and OATP2 (Staudinger et al.”
BackgroundInfluentialKavanagh, K. L., Jörnvall, H., Persson, B., & Oppermann, U. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8588-y · Cited by 908
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial
Beuers, U., Spengler, U., Kruis, W., Aydemir, Ü., Wiebecke, B., Heldwein, W., Weinzierl, M., Pape, G. R., Sauerbruch, T., & Paumgartner, G. (1992) · Hepatology · doi:10.1002/hep.1840160315 · Cited by 448 · cited 1×
“UDCA, which can be used as an therapeutic agent for the non-surgical dissolution of gallstones as well as for the treatment of primary sclerosing cholangitis and primary biliary cirrhosis (Beuers et al. 1992).”
BackgroundFXR, a multipurpose nuclear receptor
Lee, F. Y., Lee, H., Hubbert, M. L., Edwards, P. A., & Zhang, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.08.002 · Cited by 344 · cited 3×
“…genes involved in bile acid (e.g., BSEP, MRP2) and phospholipid (e.g., human MDR3 or mouse Mdr2) secretion across the bile canalicular membrane, bile acid transport (ASBT, NTCP, IBABP, OSTa–OSTb), and bile acid conjugation and detoxification (e.g., SULT2A1, UGT2B4, BACS, BAT) (Lee et al. 2006).”
BackgroundABCB4 gene mutation-associated cholelithiasis in adults
Rosmorduc, O., Hermelin, B., Boelle, P., Parc, R., Taboury, J., & Poupon, R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00898-9 · Cited by 282
Wells, J. E., & Hylemon, P. B. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.3.1107-1113.2000 · Cited by 154
The Role of Gallbladder Emptying in Gallstone Formation During Diet–Induced Rapid Weight Loss
Gebhard, R. L., Prigge, W. F., Ansel, H. J., Schlasner, L., Ketover, S. R., Sande, D., Holtmeier, K., & Peterson, F. J. (1996) · Hepatology · doi:10.1002/hep.510240313 · Cited by 113 · cited 2×
“…is also indirectly supported by the observation that daily CCK injection during total parenteral nutrition or inclusion of dietary fat to enhance CCK release during rapid weight loss restores gallbladder contractility and can prevent gallstone formation (Gebhard et al. 1996; Sitzmann et al. 1990).”
BackgroundBaron, S. F., Franklund, C. V., & Hylemon, P. B. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.15.4558-4569.1991 · Cited by 80 · cited 1×
“Genes encoding for 7a-HSDHs have been cloned from E. coli (Yoshimoto et al. 1991), B. fragilis (Bennett et al. 2003), Clostridium sordellii (Coleman et al. 1994), and Eubacterium sp (Baron et al. 1991) strains.”
Background
Cited by
Microbial impact on cholesterol and bile acid metabolism: current status and future prospects
Kriaa, A., Bourgin, M., Potiron, A., Mkaouar, H., Jablaoui, A., Gérard, P., Maguin, E., & Rhimi, M. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r088989 · Cited by 264
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma
Chai, X., Wang, J., Li, H., Gao, C., Li, S., Wei, C., Huang, J., Tian, Y., Yuan, J., Lu, J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2022.2156255 · Cited by 152
“In particular, due to the presence of enterohepatic circulation (EHC), some substances are excreted into the intestine via the bile, reabsorbed in the intestine, and eventually returned to the liver via the portal vein.(40,41) Considering that this mechanism of hepatic-intestinal circulation is likely to create condit…”
BackgroundSelf-citationKundu, S., Kumar, S., & Bajaj, A. (2015) · IUBMB Life · doi:10.1002/iub.1399 · Cited by 56
“Abnormalities or malfunctioning of enterohepatic circulation may also lead to formation of gallstones (55).”
Background
Metadata
- Authors
- Cai, J.-S., & Chen, J.-H.
- Venue
- The Journal of Membrane Biology
- Published
- 2014-08-09
- Volume
- 247
- Issue
- 11
- Pages
- 1067-1082
- ISSN
- 0022-2631 (ISSN-L)
- 1432-1424
- OpenAlex
- W2055125523
- Cited by
- 82
- References
- 18
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.